Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...

Discover 7 effective dietary strategies to control gestational diabetes naturally, supporting healthy blood sugar levels ...

The company says it plans to separate the two entities within 18 months but will still need to get the approval of the ...

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...

Medtronic has announced it intends to separate its diabetes business, which represented 8% of revenue and 4% of segment operating profit in fiscal year 2025, into a new standalone ...

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

Medtronic bumped up its dividend payout and unveiled plans to spin off its diabetes business as the medical-device company targeted revenue growth for the new fiscal year of roughly 5%.

Using Sernova Biotherapeutics' investigational Cell Pouch Bio-hybrid Organ, transplanted human donor islet cells helped ...

Exercise can play an important role in your type 2 diabetes management plan. But picking and sticking with a fitness routine ...